What is the Projected CAGR value of the Choroidal Neovascularization Market ?
Choroidal Neovascularization Market is expected to grow at a CAGR of 5.28% during the forecasting period 2024-2031.
Who are the Key Players of Choroidal Neovascularization Market ?
Some of the key players contributing to the market's growth include Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann –La Roche AG,MaaT Pharma Novartis AG, Pfizer Inc, Quark Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, Suzuken Co.Ltd.